BACKGROUND
The use of azoles for antifungal prophylaxis after familial allogeneic
stem cell transplantation in children (SCT) is hindered by adverse
events and drug interactions especially in children affected by sickle
cell disease. Intermittent, higher dose of micafungin could be an
alternative.